or
Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 25 brain tumour PhD Projects, Programmes & Scholarships for Self-funded Students
brain tumour PhD Projects, Programmes & Scholarships for Self-funded Students
We have 25 brain tumour PhD Projects, Programmes & Scholarships for Self-funded Students
Cancer: Why and how do brain tumour cells invade ‘mini-brains’?
Globally, nearly 189,000 people die each year as a result of brain cancer and around 250,000 people are diagnosed with a malignant brain tumour (umbrella name. Read more
Developing a new therapeutic strategy for brain cancers: getting therapeutics directly to the tumour
Some brain cancers cannot be surgically removed, and many potent therapeutics cannot reach the tumour site. This project aims to overcome these hurdles by utilizing a recently developed multifunctional nanoparticle drug delivery system that can be injected directly into tumours. Read more
Identifying secreted biomarkers in brain cancer
Stage IV brain cancer or glioblastoma (GBM) poses a major challenge with only 5 FDA approved chemotherapeutic drugs available for treatment. Read more
Leveraging radiomics to predict glioblastoma multiforme microenvironment and personalise treatment planning
Glioblastoma multiforme (GBM) is the most common primary brain tumour, with a dismal median survival. The tumour microenvironment (TME) is the microscopic-scale environment of tissue in which a tumour evolves and is a key component that controls GBM aggressiveness. Read more
Integrating Electrical Fields with Smart Nanoparticles and Biomimetic Hydrogels for Targeted Glioblastoma Therapy
Glioblastoma (GBM) is the most aggressive and lethal primary brain tumour in adults, with a high recurrence rate and limited treatment options. Read more
Last chance to apply
Liquid biopsy biomarkers for early detection of paediatric brain tumours
Over the past four decades, significant advancements have been made in the treatment of childhood cancer, leading to a substantial increase in cure and survival rates. Read more
Vascularisation of tumour organoids for mechanistic and drug development
Gliomas such as are the most common form of brain tumour, a subset Glioblastoma (GBM) are devastating adult brain cancer with high rates of recurrence and treatment resistance. Read more
Cancer Neuroscience: Investigating the impact of non-CNS tumours on neuronal plasticity in the brain
To apply, please contact Dr Graham Sheridan at Graham.Sheridan@nottingham.ac.uk. Cancer is one of the leading causes of death worldwide, resulting in approximately 18 million new cases and 10 million deaths each year. Read more
Identification of lung cancer patients at higher risk for brain metastasis using microfluidics
Applications are invited for a three-year PhD studentship. The studentship will start on 1st January 2025. . Project Description. Read more
New Drugs for Brain Tumours: Defining the Physicochemical Parameters for Optimal Imidazotetrazine (Temozolomide) Derivative Prodrug Activation Kinetics
Research Group:
Medicines Development and Pharmaceutical Sciences
The imidazotetrazine ring system that forms the core of the anticancer drug temozolomide is a fascinating prodrug delivery device. Read more
Deconvoluting the spatial multi-omic landscape of high-grade glioma to target post-surgical residual disease
Background. High-grade gliomas are the most common cancers arising within the brain and contribute to ~190,000 brain tumour related deaths/year globally. Read more
Cancer Biology: The role of Wnt signaling in glioblastoma therapeutic resistance
Glioblastoma is a deadly brain tumour treated with surgery, radiotherapy and chemotherapy with patient survival of 6-15 months. Read more
Evaluation of Tripterygium wilfordii derived compounds as novel treatments for medulloblastoma.
Medulloblastoma is the most common paediatric malignant brain tumour, accounting for 20% of childhood brain tumours cases per annum in the United Kingdom alone, with approximately one-third of patients dying from the disease worldwide. Read more
Disruption of the Connectome in Glioblastomas
The invasive behaviour of glioblastomas (the commonest, most malignant primary brain tumour) means that local treatments won’t cure these tumours, and this diffuse invasion means that there is a disruption of normal cognitive structures. Read more
Computational modelling of the human blood-brain barrier to tackle multidrug resistance and neurodegenerative disorders (molecular dynamics/deep generative learning/AI)
By 2050 the number of people living with neurodegenerative disorders are set to double. Alzheimer’s disease in particular is set to become a public health emergency. Read more
- 1
- 2